Muscarinic antagonists
    21.
    发明授权
    Muscarinic antagonists 失效
    毒蕈碱拮抗剂

    公开(公告)号:US06890936B2

    公开(公告)日:2005-05-10

    申请号:US10425376

    申请日:2003-04-28

    CPC分类号: C07D221/20 C07D211/96

    摘要: The invention described herein are compounds in accordance with formula I: wherein R1, R2, R3, R4, R5, R6, R2, R8, R9, n, X, and Z are as defined herein, pharmaceutical compositions containing at least one compound of formula I, methods of preparation thereof, and methods of treating disorders with at least one compound of formula I or at least one compound of formula I in association with at least one acetylcholinesterase inhibitor.

    摘要翻译: 本文描述的本发明是根据式I的化合物:其中R 1,R 2,R 3,R 4, R S,R 5,R 6,R 2,R 8,R 9, SUP,n,X和Z如本文所定义,药物组合物含有至少一种式I化合物,其制备方法,以及使用至少一种式I化合物或至少一种式 I与至少一种乙酰胆碱酯酶抑制剂有关。

    Endothelin antagonists bearing pyridyl amides
    23.
    发明授权
    Endothelin antagonists bearing pyridyl amides 失效
    含有吡啶基酰胺的内皮素拮抗剂

    公开(公告)号:US5559135A

    公开(公告)日:1996-09-24

    申请号:US306271

    申请日:1994-09-14

    CPC分类号: C07D405/12 A61K45/06

    摘要: Phenoxyphenylacetic acids and derivatives of the general structural formula I ##STR1## have endothelin antagonist activity and are useful in treating cardiovascular disorders, such as hypertension, postischemic renal failure, vasospasm, cerebral and cardiac ischemia, myocardial infarction, endotoxic shock, benign prostatic hyperplasia, inflammatory diseases including Raynaud's disease and asthma.

    摘要翻译: 苯氧基苯基乙酸和一般结构式I的衍生物具有内皮素拮抗剂活性,可用于治疗心血管疾病,如高血压,缺血性肾衰竭,血管痉挛,脑和心脏缺血,心肌梗死,内毒素性休克,良性前列腺增生 ,包括雷诺氏病和哮喘的炎性疾病。